GCG and metabolic disease: Once released, GLP-1 can act locally on afferent neurons innervating the gastrointestinal tract which signal to the caudal brainstem or enteric neurons, and/or they can enter the circulation to act centrally, or on peripheral targets, to regulate metabolic disorders (42).